Xeris Pharmaceuticals(GB:0A8E)
$16.73+0.12 (+0.69%)
GB:0A8E
Xeris Pharmaceuticals Revenue
$16.73
At close:+0.12 (+0.69%)
Xeris Pharmaceuticals (0A8E) Revenue
0 Followers
Xeris Pharmaceuticals Revenue
Xeris Pharmaceuticals had a revenue of 107.22M in the quarter ending Sep 30, 2026, with 16.42%. This bring the company's revenue in the last twelve months to 368.26M, Increased 9.79%. In the fiscal year ending Dec 31, 2025, Xeris Pharmaceuticals had annual revenue of 291.85M with 43.72% growth.
- Revenue (ttm)
- 368.26M
- Revenue Growth
- 38.37%
- P/S Ratio
- 10.52
- Revenue/Employee
- $670,908
- Employees
- 435
- Market Cap
- $3.07B
Revenue Chart
Xeris Pharmaceuticals Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 291.85M | 88.78M | 43.72% |
| Dec 31, 2024 | 203.07M | 39.16M | 23.89% |
| Dec 31, 2023 | 163.91M | 53.67M | 48.68% |
| Dec 31, 2022 | 110.25M | 60.66M | 122.32% |
| Dec 31, 2021 | 49.59M | 29.16M | 142.67% |
| Dec 31, 2020 | 20.43M | 17.71M | 650.73% |
| Dec 31, 2019 | 2.72M | 257.00K | 10.43% |
| Dec 31, 2018 | 2.46M | 909.00K | 58.42% |
| Dec 31, 2017 | 1.56M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

